COLIVA, TIZIANA ANGELA
COLIVA, TIZIANA ANGELA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
2004 Bader, P; Niemeyer, C; Weber, G; Coliva, T; Rossi, V; Kreyenberg, H; Gerecke, A; Biondi, A
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection
2005 Gaipa, G; Basso, G; Maglia, O; Leoni, V; Faini, A; Cazzaniga, G; Bugarin, C; Veltroni, M; Michelotto, B; Ratei, R; Coliva, T; Valsecchi, M; Biondi, A; Dworzak, M
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia
2007 Trombini, P; Coliva, T; Nemeth, E; Mariani, R; Ganz, T; Biondi, A; Piperno, A
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
2009 Willasch, A; Gruhn, B; Coliva, T; Kalinova, M; Schneider, G; Kreyenberg, H; Steinbach, D; Weber, G; Hollink, I; Zwaan, C; Biondi, A; van der Velden, V; Reinhardt, D; Cazzaniga, G; Bader, P; Trka, J
Novel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia
2010 Lanciotti, M; Indaco, S; Bonanomi, S; Coliva, T; Mastrodicasa, E; Caridi, G; Calvillo, M; Dufour, C
Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica)
2011 Fioredda, F; Calvillo, M; Bonanomi, S; Coliva, T; Tucci, F; Farruggia, P; Pillon, M; Martire, B; Ghilardi, R; Ramenghi, U; Renga, D; Menna, G; Barone, A; Lanciotti, M; Dufour, C
Predictive factors of relapse and survival in childhood acute myeloid leukemia: Role of minimal residual disease
2011 Rizzari, C; Cazzaniga, G; Coliva, T; DE ANGELIS, C; Conter, V
Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica)
2012 Fioredda, F; Calvillo, M; Bonanomi, S; Coliva, T; Tucci, F; Farruggia, P; Pillon, M; Martire, B; Ghilardi, R; Ramenghi, U; Renga, D; Menna, G; Pusiol, A; Barone, A; Gambineri, E; Palazzi, G; Casazza, G; Lanciotti, M; Dufour, C
Constitutional and somatic deletions of the Williams-Beuren syndrome critical region in non-Hodgkin lymphoma
2014 Guenat, D; Quentin, S; Rizzari, C; Lundin, C; Coliva, T; Edery, P; Fryssira, H; Bermont, L; Ferrand, C; Soulier, J; Borg, C; Rohrlich, P
Synthesis optimization of 2-(4-N-[11C]methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB), β-amyloid PET imaging tracer for Alzheimer's disease diagnosis
2015 Coliva, A; Monterisi, C; Apollaro, A; Gatti, D; Penso, M; Gianolli, L; Perani, D; Gilardi, M; Carpinelli, A
Acute myeloid leukaemia niche regulates response to L-asparaginase
2019 Michelozzi, I; Granata, V; DE PONTI, G; Alberti, G; Tomasoni, C; Antolini, L; GAMBACORTI PASSERINI, C; Gentner, B; Dazzi, F; Biondi, A; Coliva, T; Rizzari, C; Pievani, A; Serafini, M
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis
2021 Saettini, F; Coliva, T; Vendemini, F; Moratto, D; Savoldi, G; Borlenghi, E; Masetti, R; Niemeyer, C; Biondi, A; Balduzzi, A; Bonanomi, S
New brain atlas tool for Parkinson’s disease brain analysis
2021 Belloli, S; Presotto, L; Mennuni, G; Tassan Mazzocco, M; Coliva, A; Toninelli, E; Canu, T; Bettinardi, V; Morari, M; Moresco, R
Exploring the neuroprotective effects of Montelukast treatment in a rat model of quinolinic acid-induced neurotoxicity
2021 Tassan Mazzocco, M; Murtaj, V; Belloli, S; Presotto, L; Mennuni, G; Canu, T; Coliva, A; Toninelli, E; Moresco, R
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity
2022 Guerra, F; L'Imperio, V; Bonanomi, S; Spinelli, M; Coliva, T; Dell'Acqua, F; Ferrari, G; Corti, P; Balduzzi, A; Biondi, A; Pagni, F; Saettini, F
Evaluation of prodromal markers of degeneration in a Parkinson’s disease mouse model using PET-CT imaging
2022 Belloli, S; Tassan Mazzocco, M; Parrella, E; Coliva, A; Maspero, M; Faustini, G; Bellucci, A; Pizzi, M; Moresco, R
Neuroprotective effects of Montelukast treatment in a rat model of Huntington-like neurotoxicity: a PET covariance study
2022 Tassan Mazzocco, M; Martins, D; Murtaj, V; Belloli, S; Coliva, A; Toninelli, E; Moresco, R
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome
2022 Saettini, F; Coliva, T; Vendemini, F; Galbiati, M; Bugarin, C; Masetti, R; Moratto, D; Chiarini, M; Guerra, F; Iascone, M; Badolato, R; Cazzaniga, G; Niemeyer, C; Flotho, C; Biondi, A
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy
2022 Granata, S; Valtorta, S; Zerbetto, F; Todde, S; Iannone, M; Coliva, T; Spinelli, A; Bertoli, G; de Pretis, S; Diprima, S; Villa, S; DI MUZIO, N; Moresco, R
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity
2023 Tassan Mazzocco, M; Murtaj, V; Martins, D; Schellino, R; Coliva, A; Toninelli, E; Vercelli, A; Turkheimer, F; Belloli, S; Moresco, R